CAH
48
-6
INTU
58
-3
CL
54
3
HSY
31
-6
CNX
73
-3
ILMN
32
-9
CA
22
-3
BBY
52
6
CTSH
60
-3
CSX
57
-4
AAP
35
-9
AAPL
40
-6
ETN
75
-3
COP
57
-2
LRCX
37
-9
VNO
46
-13
NEE
54
7
RIG
43
-7
KIM
72
2
ADBE
47
-9
CAH
48
-6
INTU
58
-3
CL
54
3
HSY
31
-6
CNX
73
-3
ILMN
32
-9
CA
22
-3
BBY
52
6
CTSH
60
-3
CSX
57
-4
AAP
35
-9
AAPL
40
-6
ETN
75
-3
COP
57
-2
LRCX
37
-9
VNO
46
-13
NEE
54
7
RIG
43
-7
KIM
72
2
ADBE
47
-9
Financhill
Back

BondBloxx Bloomberg FiveYrTrgDurUSTrsETF Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
29

XFIV
BondBloxx Bloomberg FiveYrTrgDurUSTrsETF

Last Price:
48.17
Seasonality Move:
1.54%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
29
BondBloxx Bloomberg FiveYrTrgDurUSTrsETF (XFIV) is a Sell

Is BondBloxx Bloomberg FiveYrTrgDurUSTrsETF a Buy, Sell or Hold?

  • The current BondBloxx Bloomberg FiveYrTrgDurUSTrsETF [XFIV] share price is $48.18. The Score for XFIV is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • XFIV is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XFIV Stock Price Chart

What is BondBloxx Bloomberg FiveYrTrgDurUSTrsETF's stock price today?

  • The BondBloxx Bloomberg FiveYrTrgDurUSTrsETF share price today is $48.18
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XFIV is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

XFIV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 33.86 Sell
Chaikin Money Flow: 2526 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (48.27 - 49.01) Sell
Bollinger Bands (100): (48.51 - 49.87) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

XFIV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.24 Sell
20-day SMA: 48.51 Sell
50-day SMA: 49.26 Sell
200-day SMA: 48.62 Sell
8-day EMA: 48.25 Sell
20-day EMA: 48.52 Sell
50-day EMA: 48.92 Sell
200-day EMA: 48.81 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

BondBloxx Bloomberg FiveYrTrgDurUSTrsETF Earnings Growth & XFIV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

BondBloxx Bloomberg FiveYrTrgDurUSTrsETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):